BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17577771)

  • 1. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis.
    Fung SS; Hillier KL; Leger CS; Sandhu I; Vickars LM; Galbraith PF; Li CH; Leitch HA
    Leuk Lymphoma; 2007 Jun; 48(6):1087-91. PubMed ID: 17577771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
    Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
    Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
    Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA
    J Clin Oncol; 2009 Aug; 27(24):3959-63. PubMed ID: 19620484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones.
    Vander Meeren S; Heyrman B; Renmans W; Bakkus M; Maes B; De Raeve H; Schots R; Jochmans K
    Ann Hematol; 2018 Jul; 97(7):1219-1227. PubMed ID: 29492600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?
    Angelillo P; Capasso A; Ghia P; Scarfò L
    Eur J Intern Med; 2018 Dec; 58():2-6. PubMed ID: 30268574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation, progression, and outcome of patients with clonal B-cell counts of less than 5 × 10(9)/l, 5 to 10 × 10(9)/l, and more than 10 × 10(9)/l and chronic lymphocytic leukemia immunophenotype.
    Foster AE; Nguyen TT; Al-Hammadi N; Frater JL; Hassan A; Kreisel F
    Am J Clin Pathol; 2015 Jan; 143(1):70-7. PubMed ID: 25511144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
    Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
    Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal B-cell lymphocytosis: from literature to laboratory practice].
    Keutgens A; Foguenne J; Gothot A; Tassin F
    Ann Biol Clin (Paris); 2016; 74(2):168-75. PubMed ID: 27029722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Ryder CB; Oduro KA; Moore EM
    Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
    Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.
    Strati P; Shanafelt TD
    Blood; 2015 Jul; 126(4):454-62. PubMed ID: 26065657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
    Shanafelt TD; Kay NE; Jenkins G; Call TG; Zent CS; Jelinek DF; Morice WG; Boysen J; Zakko L; Schwager S; Slager SL; Hanson CA
    Blood; 2009 Apr; 113(18):4188-96. PubMed ID: 19015397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
    Scarfò L; Ghia P
    Semin Oncol; 2016 Apr; 43(2):201-8. PubMed ID: 27040697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal B-cell lymphocytosis: update on diagnosis, clinical outcome, and counseling.
    Parikh SA; Kay NE; Shanafelt TD
    Clin Adv Hematol Oncol; 2013 Nov; 11(11):720-9. PubMed ID: 24896545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal B-cell lymphocytosis: physiological entity or preliminary stage of chronic lymphocytic leukaemia?].
    Schindhelm RK; van Marwijk Kooy MR; Coenen JL; Huijgens PC; Kuiper-Kramer PA
    Ned Tijdschr Geneeskd; 2010; 154():A1520. PubMed ID: 20482911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?
    Shanafelt TD; Kay NE; Call TG; Zent CS; Jelinek DF; LaPlant B; Morice WG; Hanson CA
    Leuk Res; 2008 Sep; 32(9):1458-61. PubMed ID: 18179821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of monoclonal B-cell lymphocytosis.
    Mowery YM; Lanasa MC
    Cancer Control; 2012 Jan; 19(1):8-17. PubMed ID: 22143058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications.
    Molica S; Mauro FR; Molica M; Del Giudice I; Foà R
    Leuk Lymphoma; 2012 Sep; 53(9):1660-5. PubMed ID: 22335530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal B-cell lymphocytosis.
    Maitre E; Troussard X
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):229-238. PubMed ID: 31585623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.
    Slager SL; Lanasa MC; Marti GE; Achenbach SJ; Camp NJ; Abbasi F; Kay NE; Vachon CM; Cerhan JR; Johnston JB; Call TG; Rabe KG; Kleinstern G; Boddicker NJ; Norman AD; Parikh SA; Leis JF; Banerji V; Brander DM; Glenn M; Ferrajoli A; Curtin K; Braggio E; Shanafelt TD; McMaster ML; Weinberg JB; Hanson CA; Caporaso NE
    Blood; 2021 Apr; 137(15):2046-2056. PubMed ID: 33512457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.